History
  • No items yet
midpage
GRAVLEY v. FRESENIUS VASCULAR CARE, INC.
2:24-cv-01148
E.D. Pa.
Jul 24, 2025
Read the full case

Background

  • Plaintiffs filed a putative class action against Fresenius Vascular Care, Inc. (Azura Vascular Care) alleging a data breach compromising patient information.
  • Plaintiffs alleged claims under state law, including negligence, breach of fiduciary duty, breach of implied contract, unjust enrichment, and consumer protection violations.
  • The parties reached a mediated settlement, creating a $3.15 million non-reversionary fund; class members could claim up to $10,000 for documented losses or receive a pro rata cash payment (estimated $134.77 per claimant).
  • The class included 333,798 members; notice was provided via email, mail, website, and press release, with minimal opt-outs and no objections.
  • Plaintiffs moved for final approval of settlement and attorneys’ fees; following a fairness hearing and additional submissions, the court also addressed fee reasonableness.
  • The court found the settlement fair and reasonable but reduced the requested attorney fee award from 35% to 25% of the common fund, based on limited litigation and efficiency concerns.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Is the class action settlement fair, reasonable, and adequate? Settlement is in best interest of class; addresses harm from data breach Not opposed, negotiated terms at arms-length Settlement is fair, reasonable, and adequate; final approval granted
Does the proposed class meet Rule 23 certification requirements? All criteria (numerosity, commonality, typicality, adequacy) are satisfied Not opposed after mediation and agreement Class certification requirements met for settlement purposes
Are the requested attorneys’ fees reasonable? 35% of fund appropriate given size, results, and counsel’s expertise Limited objection; defendant pays fund, not fees directly 25% of fund awarded due to early settlement and high billed hours
Is the proposed notice to class members sufficient? Notice plan is comprehensive and compliant with due process Not challenged Notice method approved as adequate

Key Cases Cited

  • In re Prudential Ins. Co. of Am. Sales Practice Litig., 148 F.3d 283 (3d Cir. 1998) (articulating standards for class action settlement approval)
  • Girsh v. Jepson, 521 F.2d 153 (3d Cir. 1975) (establishing factors for evaluating reasonableness of class settlements)
  • In re Warfarin Sodium Antitrust Litig., 391 F.3d 516 (3d Cir. 2004) (regarding reasonableness of fees and fairness of settlement)
  • In re General Motors Corp. Pick-Up Truck Fuel Tank Prods. Liab. Litig., 55 F.3d 768 (3d Cir. 1995) (evaluating reasonableness of fees in common fund cases)
  • Rodriguez v. Nat'l City Bank, 726 F.3d 372 (3d Cir. 2013) (interpreting commonality under Rule 23)
Read the full case

Case Details

Case Name: GRAVLEY v. FRESENIUS VASCULAR CARE, INC.
Court Name: District Court, E.D. Pennsylvania
Date Published: Jul 24, 2025
Citation: 2:24-cv-01148
Docket Number: 2:24-cv-01148
Court Abbreviation: E.D. Pa.